by Jeremy Gordon, The Duran:
Fake news is keeping us away from the treatment to end the coronavirus crisis
The anti-hydroxychloroquine media has been full of the supposed dangers of hydroxychloroquine and its failure as a treatment for the virus. Does hydroxychloroquine work or does it not, is it safe or dangerous, and should we be using it as a treatment for the virus? Here we examine the evidence for and against it.
A New York doctor Vladimir Zelenko looked at treatments being used in China and Korea and gave it to 405 patients over 60 or with high-risk problems such as diabetes, asthma, obesity, hypertension or shortness of breath. In this high risk group he claimed to have cut hospital admission and mortality rates compared to what could be expected without treatment by 80 to 90%. https://internetprotocol.co/hype-news/2020/04/14/a-detailed-coronavirus-treatment-plan-from-dr-zelenko/
Dr Zelenko sent a letter to President Trump urging him to issue an executive order to roll out the treatment which the FDA was blocking. Trump announced that hydroxychloroquine looked like it could be a “game-changer”, and thus the politicization of hydroxychloroquine began.
Dr Fauci the director of the National Institute of Allergy and Infectious Diseases who was supposed to be advising Trump disagreed with him and backed Gilead’s rival treatment Remdesivir. YouTube deleted a video of Dr. Zelenko talking about the treatment on his Rabbi’s channel and despite objections that there was nothing wrong with the video YouTube never reinstated it.
In this YouTube video interview with Rudy Giulliani from July 1, which hopefully will not be deleted by the time you read this, Dr. Zelenko claims 99,3% survival rate for the high-risk patients he has treated. https://www.youtube.com/watch?v=TFwjY0qe7ro
Professor Didier Raoult of Marseilles used a similar protocol to Dr. Zelenko without the zinc. His study with a small group using hydroxychloroquine and azithromycin showed a fifty-fold benefit. He then went on to get similar results with a much larger group of 1,061 patients. Contrary to the warnings the media had been running that hydroxychloroquine would cause heart problems, no cardiac toxicity was observed and he achieved a mortality rate of only 0.5%. http://covexit.com/professor-didier-raoult-releases-the-results-of-a-new-hydroxychloroquine-treatment-study-on-1061-patients/
The media quickly found critics who claimed that the only valid proof any treatment worked was a “gold-standard” double-blind clinical trial and dismissed Dr. Zelenko’s and Raoult’s results. Dr. Zelenko and Prof. Raoult both refused on ethical grounds to give placebos to half the patients in clinical trials and they defended their data as sufficient to show the treatment did work. They both stressed that the urgency of the situation made it necessary to act on available evidence, not clinical trials which would take months to produce results and be verified. There have subsequently been over a dozen studies which confirm that Dr. Zelenko’s and Prof. Raoult’s protocols do work.
A study from the New York University Grossman school of Medicine published in May found patients given hydroxychloroquine and azithromycin at an early stage had a lower need for hospitalization than those who were not. The addition of zinc improved the results even more. https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1.full.pdf
“I’ll tell you what. If this is me, and I am me, and I end up getting this thing, I am going to want Zinc plus Hydroxychloroquine plus Azithromycin. I would want that treatment.” commented Chris Martenson, PhD, in his video series about COVID-19 where he talks about this study. http://covexit.com/i-am-going-to-want-zinc-plus-hydroxychloroquine-plus-azithromycin-chris-masterson-phd/
Yale Professor Harvey Risch submitted a report of five trials and studies using hydroxychloroquine in the American Journal of Epistemology titled “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis. https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1.
Prof. Risch agreed that, in an ideal world, randomized double-blinded controlled clinical trials would be preferable but in the meantime “for the great majority I conclude that hydroxychloroquine and azithromycin, preferably with zinc can be this outpatient treatment, at least until we find or add something better. It is our obligation not to stand by as the old and infirm are killed by this disease and our economy is destroyed by it and we have nothing to offer except high-mortality hospital treatment. Available evidence of efficacy of HCQ+AZ has been repeatedly described in the media as anecdotal, but most certainly is not” http://covexit.com/yale-epidemiology-professor-urges-hydroxychloroquine-azithromycin-early-therapy-for-covid-19/